A Meta-Analysis of Research on Motivational Interviewing Treatment Effectiveness (MARMITE) Jennifer Hettema Julie Steele William R. Miller Annual Review.

Slides:



Advertisements
Similar presentations
N T C S at UGA * Funded by National Institute on Drug Abuse and Robert Wood Johnson Foundation Adoption of Evidence-based Practices in Addiction Treatment.
Advertisements

Applying Motivational Interviewing to Geriatric Medicine Keri Bolton Oetzel, Ph.D., MPH Carla Herman, MD, MPH Lisa Gibbs, MD Supported by a grant from.
Abstract People who enter substance abuse treatment under various degrees of legal pressure do at least as well at the end of treatment or at follow-up.
Predictors of Change in HIV Risk Factors for Adolescents Admitted to Substance Abuse Treatment Passetti, L. L., Garner, B. R., Funk, R., Godley, S. H.,
Background: The low retention rates among African Americans in substance abuse treatment (Milligan et al., 2004) combined with the limited number of treatments.
Jennifer A. Rechichi Bureau of Quality Improvement Office of Program Accountability Florida Department of Juvenile Justice Motivational Interviewing: A.
SBIRT: Screening, Brief Intervention, Referral to Treatment
HIV Risk Behaviors and Alcohol Intoxication among Injection Drug Users in Puerto Rico Tomás D. Matos, MS Center for Addiction Studies Universidad Central.
C. Andres Bedoya, PhD Behavioral Medicine Service Department of Psychiatry Massachusetts General Hospital / Harvard Medical School Factors related to high-risk.
Efficacy of Brief Motivational Intervention with Young Adults to Address Alcohol Use and Related Problems Jean-Bernard Daeppen Jacques Gaume, Nicolas Bertholet,
Youth mentoring and the well-being of young people: Evidence from an Irish mixed- methods evaluation Dr Bernadine Brady Child & Family Research Centre.
Introduction To Motivational Interviewing Darryl Tonemah Ph.D.
Experimental Psychology PSY 433 Chapter 3 Experiments -- Designs.
Substance-Use Disorders Lori Ridgeway PSYC What is abuse? Criteria Failure to meet responsibilities Use despite potential dangers Legal problems.
Motivational Interviewing to Improve Treatment Engagement and Outcome* The effect of one session on retention Research findings from the NIDA Clinical.
Challenges and Successes Treating Adolescent Substance Use Disorders Janet L. Brody, Ph.D. Center for Family and Adolescent Research (CFAR), Oregon Research.
Motivational Interviewing in Mental Health Treatment
Teaching medical students in early interventions in “New chances for early interventions in the general practice” Jean-Bernard Daeppen, Lausanne, Switzerland.
The University of Georgia Use of ASAM PPC: Data from a National Sample of Addiction Treatment Programs J. Aaron Johnson, PhD The University of Georgia.
Community Reinforcement and Family Training (CRAFT) with Concerned Significant Others of Problem Gamblers Nicole Peden & David C. Hodgins University of.
Criminal Justice Drug Abuse Treatment Studies American Society of Criminology November 16, 2011.
Results of a Brief Intervention for Reducing Alcohol Use among HIV Positive Women in Cape Town, South Africa This study was funded by NICHD grant number.
Studying treatment of suicidal ideation & attempts: Designs, Statistical Analysis, and Methodological Considerations Jill M. Harkavy-Friedman, Ph.D.
Research Strategies to Test Behavioral/Psychotherapy Treatments for Substance Use Disorders: Several Examples Richard A. Rawson, Ph.D UCLA ISAP Cairo,
A. FORCEHIMES K. WILSON T. MOYERS J. TILLMAN C. DUNN C. LIZARRAGA C. RIPP Intervention Training, Supervision and Fidelity Monitoring in NIDA CTN 0047:
UCLA Integrated Substance Abuse Programs (ISAP). CSAT MTP Project Goals: To study the clinical effectiveness of the Matrix Model To study the clinical.
The Efficacy of Motivational Interviewing: A Meta-Analysis of Controlled Clinical Trials By Brian L. Burke, Hal Arkowitz, and Marisha Menchola Presented.
ILLNESSES, INJURIES, AND HOSPITALIZATIONS AMONG INNER-CITY MINORITY INFANTS IN CHICAGO.
Factors that Influence Retention in Greek Therapeutic Communities Erianna Daliani MSc (Gerasimos Papanastasatos) KETHEA Research Dept. 11th European Conference.
Motivational Enhancement Therapy Talking About Gambling… It’s simple, but not easy A GRI Gambling Research Conference 2007 New Developments in Treatment.
A Typology of Homeless Youth Paul A. Toro, Ph.D., Dept. of Psychology, Wayne State University, Detroit, MI Webinar, March 22, 2012 This powerpoint presentation.
Audrey J. Brooks, PhD University of Arizona CA-AZ node.
Evidence-Based Practice: Psychosocial Interventions Maxine Stitzer, Ph.D. Johns Hopkins Univ SOM NIDA Blending Conference June 3, 2008 Cincinnati, Ohio.
Clinical Trials and Patient Education for Smoking Cessation Maureen George PhD RN AE- C FAAN University of Pennsylvania School of Nursing.
1 / 27 California Educational Research Association 88 th Annual Conference Formative Assessment: Implications for Student Learning San Francisco, CA November.
Lecture 16 (Oct 28, 2004)1 Lecture 16: Introduction to the randomized trial Introduction to intervention studies The research question: Efficacy vs effectiveness.
Lecture 17 (Oct 28,2004)1 Lecture 17: Prevention of bias in RCTs Statistical/analytic issues in RCTs –Measures of effect –Precision/hypothesis testing.
The NIDCR funded Collaborating Research Centers to Reduce Oral Health Disparities (CRCROHD) represent an innovative approach to understanding determinants.
Chapter 10 Counseling At Risk Children and Adolescents.
Components of a causal relationship Does a change in X cause a change in Y? There are 3 components: 1) Co ‑ variation of events 2) Time ‑ order relationship.
DEVELOPMENT OF SURVEY FROM AN ITEM BANK For Counselors Motivational Interviewing Performance Management and Vocational Rehabilitation Program Evaluation.
Meta-Analysis of HIV Risk Reduction Interventions Within Drug Abuse Treatment Programs By: Dana Trent June 2001
AHSR 2008 Meeting-Boston MA Reduced Days of Heavy Drinking After SBIRT Differences in patient outcomes by problem severity and client characteristics InSight.
Farrokh Alemi, Ph.D., Mary Haack, Ph.D., Susie Nemes, Ph.D., Angela Harge, M.Ed., Heibatollah Baghi, Ph.D. This research was supported by a grant from.
Raymond F. Anton, MD for The COMBINE Study Research Group
INTRODUCTION TO MOTIVATIONAL INTERVIEWING Lynn S. Massey, LMSW Department of Psychiatry Department of Emergency Medicine University of Michigan.
The COMBINE Study: Design and Methodology Stephanie S. O’Malley, Ph.D. for The COMBINE Study Research Group JAMA Vol. 295, , 2006 (May 3 rd.
N T C S at UGA * Funded by National Institute on Drug Abuse and Robert Wood Johnson Foundation Program Emphasis on Spirituality and Adoption of Evidence-based.
How to read a paper D. Singh-Ranger. Academic viva 2 papers 1 hour to read both Viva on both papers Summary-what is the paper about.
Chapter 6 Subset of Overview by Gender GAIN Coordinating Center (11/21/2012). Normal, IL: Chestnut Health Systems. November Available from
The University of Georgia Training and exposure to evidence-based practices: Changing attitudes among the addiction treatment workforce J. Aaron Johnson,
1 Clinical Supervision in the CTN: Availability, Content, and Impact on Counselors Lori J. Ducharme, Hannah K. Knudsen, J. Aaron Johnson & Paul M. Roman.
1 Is the ACT model effective in a contemporary Danish psychiatric setting? Preliminary Results from a Danish Multi-centre Trial of Assertive Community.
Vivia V. McCutcheon, Howard J. Edenburg, John R. Kramer, Kathleen K. Bucholz 9 th Annual Guze Symposium St. Louis, MO February 19, 2009 Gender Differences.
Predictors of study retention in addiction treatment trials KORTE JE 1, MAGRUDER KM 1,2, KILLEEN TK 1, SONNE SC 1, SAMPSON RR 1 and BRADY KT 1,2 1. Medical.
TOBACCO TACTICS: BRINGING THE PROGRAM TO THE SMOKER Sonia A. Duffy, PhD, RN 1,2 ; Lee A. Ewing, MPH 2 ; Carrie A. Karvonen-Gutierrez, MPH 2 ; David L.
Motivational Interviewing. a directive, client-centered counseling style for eliciting behavior change by helping clients to explore and resolve ambivalence.
Cleveland Municipal Drug Court: SAMHSA CSAT Adult Treatment Drug Court Grant Dr. Margaret Baughman Madison Wheeler, BS Paul Tuschman, BA Begun.
The MDFT Model And Some Notes on Germany Andreas Gantner.
Describing health baselines Session 6 Health in SEA.
Medication Adherence and Substance Abuse Predict 18-Month Recidivism among Mental Health Jail Diversion Program Clients Elizabeth N. Burris 1, Evan M.
School of Allied Health Professions & School of Medicine, Health Policy & Practice LAMP A pragmatic unblinded randomised controlled trial and economic.
Life in the FASTLANE: Reducing high-risk sexual behaviors among HIV-, heterosexual meth users Thomas L. Patterson, PhD; Brent Mausbach, PhD; Shirley Semple,
Improvement & Behaviour Change
Predictors of study retention in drug abuse treatment trials
Can Primary Care Physicians Learn and Adopt Brief Motivational Interviewing Techniques in their Practice? Alan Adelman, MD, MS David Richard, MD Robert.
Motivational Interviewing
Sherry Deren, Sung-Yeon Kang, Milton Mino & Honoria Guarino
فوق تخصص کودک،نوجوان و خانواده
Presentation transcript:

A Meta-Analysis of Research on Motivational Interviewing Treatment Effectiveness (MARMITE) Jennifer Hettema Julie Steele William R. Miller Annual Review of Clinical Psychology Vol 1, 2005 (in press)

funded by a grant from The Robert Wood Johnson Foundation

Adoption Curve for Innovations Source: Everett M. Rogers Diffusion of Innovations

Number of MI Publications Source: MARMITE

MI Outcome Trials Source: MARMITE

Inclusion Criteria for MI Trials For within-group effect sizes: At least one treatment group including MI At least one treatment group including MI At least one post-treatment outcome measure At least one post-treatment outcome measure For between-group effect sizes: At least one control or comparison condition without MI components At least one control or comparison condition without MI components Procedure for creating pre-treatment equivalence of groups Procedure for creating pre-treatment equivalence of groups MARMITE

All studies double-coded for: Methodological quality on 12 dimensions Methodological quality on 12 dimensions Other study characteristics Other study characteristics Attributes of the MI intervention(s) Attributes of the MI intervention(s) Within-group effect sizes Within-group effect sizes Between-group effect sizes Between-group effect sizes MARMITE

Effect sizes were computed: For all reported outcome variables For all reported outcome variables At all reported follow-up points At all reported follow-up points For all between-group contrasts For all between-group contrasts With 95% confidence intervals With 95% confidence intervals Correcting for small sample bias Correcting for small sample bias MARMITE

72 studies included so far: Alcohol (31) One study each: Alcohol (31) One study each: Drug Abuse (14)Gambling Drug Abuse (14)Gambling Smoking (6)Eating Disorders Smoking (6)Eating Disorders HIV Risk (5)Relationships HIV Risk (5)Relationships Treatment Compliance (5) Treatment Compliance (5) Water purification (4) Water purification (4) Diet and exercise (4) Diet and exercise (4) MARMITE

Types of Comparisons MI vs. Specified Treatment (25) MI vs. Specified Treatment (25) MI vs. Treatment as Usual (6) MI vs. Treatment as Usual (6) MI vs No Treatment / Placebo (21) MI vs No Treatment / Placebo (21) MI added to Specified Treatment (7) MI added to Specified Treatment (7) MI added to Treatment as Usual (5) MI added to Treatment as Usual (5) Mixed Designs (6) Mixed Designs (6) Within-Group Only (2) Within-Group Only (2) MARMITE

Methodological Quality Compared to 361 alcohol treatment trials: MQS Mean = vs (ns) MQS Mean = vs (ns) Intervention quality control78% vs 57% Intervention quality control78% vs 57% Multisite trials:28% vs. 5% Multisite trials:28% vs. 5% Follow-up > 12 months18% vs. 51% Follow-up > 12 months18% vs. 51% Follow-up completion > 70%45% vs. 75% Follow-up completion > 70%45% vs. 75% MARMITE

Outcome (Dependent) Measures Mean of 3.3 outcome variables per study Mean of 3.3 outcome variables per study Range: 1 to 12 Range: 1 to 12 To avoid capitalization on change, we computed a combined effect size (d) averaging across all reported outcome variables in each study To avoid capitalization on change, we computed a combined effect size (d) averaging across all reported outcome variables in each study MARMITE

Specified Characteristics of MI Being collaborative Being collaborative Client centered Client centered Nonjudgmental Nonjudgmental Building trust Building trust Reducing resistance Reducing resistance Increasing readiness Increasing readiness Increasing self-efficacy Reflective listening Increasing discrepancy Eliciting change talk Exploring ambivalence Expressing empathy MARMITE

Specified Characteristics of MI Of 12 possible characteristics of MI, The average number mentioned was 3.6 Range: 0-12 MARMITE

Treatment “Dose” of MI Average “dose” of 2 sessions (2.2 hours) The contrasts in dose varied from: Comparison group 25 hours longer than MI to MI 6 hours longer than no-treatment MARMITE

Quality Control of MI Average training time: 10 hours (N=13) Average training time: 10 hours (N=13) Manual-guided 74% Manual-guided 74% Post-training supervision 29% Post-training supervision 29% Fidelity checks 36% Fidelity checks 36% MARMITE

Where was MI tested? Outpatient clinics (15) Outpatient clinics (15) Inpatient facilities (11) Inpatient facilities (11) Educational settings (6) Educational settings (6) Community organizations (5) Community organizations (5) G.P. offices (5) G.P. offices (5) Prenatal clinics (3) Prenatal clinics (3) Emergency rooms (2) Emergency rooms (2) Halfway house (2) EAP Telephone (3) In home (1) Jail (1) Mixed (7) Unspecified (8) MARMITE

Who delivered MI? Paraprofessionals / students (8) Paraprofessionals / students (8) Master’s level (6) Master’s level (6) Psychologists (6) Psychologists (6) Nurses (3) Nurses (3) Physicians (2) Physicians (2) Dietician (1) Dietician (1) Mixed (22) Mixed (22) MARMITE

Sample Characteristics (N = 14,267) N = 21 to 952Mean = 198 N = 21 to 952Mean = 198 Males = 54.8% Range = 0 to 100% Males = 54.8% Range = 0 to 100% Mean Age = 34Range = 16 to 62 Mean Age = 34Range = 16 to 62 Ethnic minorities: 43%(N = 37) Ethnic minorities: 43%(N = 37) MARMITE

Some Generalizations Wide variability in effect size across studies, within problem areas (e.g., for alcohol problems, d varies from 0 to 3.0) Wide variability in effect size across studies, within problem areas (e.g., for alcohol problems, d varies from 0 to 3.0) Effects of MI appear early Effects of MI appear early Effects of MI diminish over time, except in additive studies Effects of MI diminish over time, except in additive studies  d =.77 at post-treatment  d =.31 at 4-6 months  d =.30 at 6-12 months MARMITE

Effect Size of MI Over Time MARMITE Controlled Additive Comparative

Effect size was not predicted by: Number of MI attributes mentioned Number of MI attributes mentioned Methodological quality of study, except Methodological quality of study, except Use of a manual to guide MI did predict effect size:  Studies not using a manuald =.65  Studies using a manuald =.37 Demographic characteristics, except: Demographic characteristics, except:  Anglo/Caucasian samplesd =.39  Minority samplesd =.79 MARMITE

Effect size varied with outcome measures Alcohol: Quantity of drinkingd =.30 Quantity of drinkingd =.30 Frequency of drinkingd =.31 Frequency of drinkingd =.31 BAC estimatesd =.22 BAC estimatesd =.22 Negative consequencesd =.08 Negative consequencesd =.08 HIV Risk: Knowledged = 1.46 Knowledged = 1.46 Behavioral Intentionsd =.88 Behavioral Intentionsd =.88 Sexual risk-takingd =.07 Sexual risk-takingd =.07 MARMITE

Mean Combined Effect Size by Problem Area ( N=72 Clinical Trials) MARMI TE

Conclusions 1. Robust and enduring effects when MI is added at the beginning of treatment  MI increases treatment retention  MI increases treatment adherence  MI increases staff-perceived motivation MARMITE

Conclusions 2. The effects of motivational interviewing emerge relatively quickly (This is also true of other treatments) MARMITE Project MATCH Outcomes

Conclusions 2a. The effects of motivational interviewing emerge relatively quickly  This may not be true for certain problem areas or dependent measures where “sleeper” effects occur (e.g., effects of diet and exercise) MARMITE

Conclusions 3. The between-group effects of motivational interviewing tend to diminish over 12 months  This is also true of other treatments  Between-group differences diminish in part because control/comparison groups “catch up” over time  This may not be true of MI’s additive effects with other treatment MARMITE

Conclusions 4. The effects of MI are highly variable across sites and providers  This is also true of other treatments, but may be more true with MI  Provider baseline characteristics do not predict effectiveness with MI  Treatment process variables do  Manuals may not be a good idea MARMITE